Welcome to CDC stacks | Therapeutic Monitoring of Voriconazole in Children Less Than 3 Years of Age: A Case Report and Summary of Voriconazole Concentrations for 10 Children - 33364 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Therapeutic Monitoring of Voriconazole in Children Less Than 3 Years of Age: A Case Report and Summary of Voriconazole Concentrations for 10 Children
Filetype[PDF-71.11 KB]


Details:
No Related Documents.
You May Also Like:
  1. Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
    Personal Author:
    Stockmann, Chris; Constance, Jonathan E.; Roberts, Jessica K.; Olson, Jared; Doby, Elizabeth H.; Ampofo, Krow; Stiers, Justin; Spigarelli, Michael G.; Sherwin, Catherine M. T.;
    Published:
    May 2014
    Source:
    Clin Pharmacokinet. 53(5):429-454.
    Description:
    Invasive fungal infections are a significant cause of morbidity and mortality in children. Successful management of these systemic infections requires identification of the causative pathogen, appropriate antifungal selection, and optimisation of its...
    File Type:
    Filetype[PDF - 600.99 KB]
  2. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents : recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). National Institutes of Health (U.S.). HIV Medicine Association.. United States. AIDSinfo. Opportunistic Infections Working Group..
    Published:
    October 21, 2015; last reviewed May 7, 2013
    Description:
    Sections updated frequently: see "What's New in the Guidelines" at https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-oi-prevention-and-treatment-guidelines/392/whats-new : The Guidelines for the Prevention and Treatment o...
    Status:
    current
    File Type:
    Filetype[PDF - 5.97 MB]
  3. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children; recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics
    Personal Author:
    Danner, Susie P.; Dominguez, Kenneth L.; Mofenson, Lynne M.; Nesheim, Steven R.;
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). American Academy of Pediatrics. Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. National Institutes of Health (U.S.). Pediatric Infectious Diseases Society.
    Published:
    September 4, 2009
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2009; 58(RR-11):1-166.
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11
    Description:
    This report updates and combines into one document earlier versions of guidelines for preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected children, last published in 2002 and 2004, respectively. These guidelines ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 2.08 MB]
  4. Treating opportunistic infections among HIV-infected adults and adolescents; recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America
    Personal Author:
    Benson, Constance A.; Kaplan, Jonathan E.; Masur, Henry; Pau, Alice; Holmes, King K.;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. Infectious Diseases Society of America. National Center for HIV, STD and TB Prevention (U.S.). National Institutes of Health (U.S.).
    Published:
    December 17, 2004
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-15
    Clinical infectious diseases ; v. 40, suppl. 3
    Description:
    "The National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and CDC have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunod...
    File Type:
    Filetype[PDF - 1.85 MB]
  5. Treating opportunistic infections among HIV-exposed and infected children; recommendations from the Ceters for Disease Control and Prevention, the National Institutes of Health, and the Infectious Diseases Society of America
    Personal Author:
    Mofenson, Lynne M.
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Infectious Diseases Society of America. National Center for HIV, STD and TB Prevention (U.S.). National Institutes of Health (U.S.).
    Published:
    December 3, 2004
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-14
    Clinical infectious diseases ; v. 40, suppl. 1
    Description:
    "In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a compan...
    File Type:
    Filetype[PDF - 742.29 KB]